Clinical Trial Update: Use of Ranibizumab With Mitomycin C During Trabeculectomy [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluated the use of ranibizumab with mitomycin C during trabeculectomy for glaucoma, with results posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glaucoma

Drugs mentioned

• Mitomycin-C (mitomycin C)
• Ranibizumab (Lucentis) (ranibizumab)

Snippet

Sponsor: University of Colorado, Denver | Conditions: Glaucoma | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2016-10-13